Editas Medicine (EDIT) Accounts Payables: 2015-2025
Historic Accounts Payables for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to $3.2 million.
- Editas Medicine's Accounts Payables fell 74.68% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 74.68%. This contributed to the annual value of $5.5 million for FY2024, which is 33.57% down from last year.
- As of Q3 2025, Editas Medicine's Accounts Payables stood at $3.2 million, which was down 52.95% from $6.7 million recorded in Q2 2025.
- Over the past 5 years, Editas Medicine's Accounts Payables peaked at $13.8 million during Q2 2024, and registered a low of $3.2 million during Q3 2025.
- Over the past 3 years, Editas Medicine's median Accounts Payables value was $8.1 million (recorded in 2023), while the average stood at $8.3 million.
- Per our database at Business Quant, Editas Medicine's Accounts Payables spiked by 100.94% in 2022 and then slumped by 74.68% in 2025.
- Editas Medicine's Accounts Payables (Quarterly) stood at $5.0 million in 2021, then spiked by 88.34% to $9.5 million in 2022, then decreased by 13.06% to $8.3 million in 2023, then slumped by 33.57% to $5.5 million in 2024, then plummeted by 74.68% to $3.2 million in 2025.
- Its Accounts Payables was $3.2 million in Q3 2025, compared to $6.7 million in Q2 2025 and $5.5 million in Q1 2025.